Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease
- PMID: 16166585
- PMCID: PMC1895417
- DOI: 10.1182/blood-2005-07-2839
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease
Abstract
Because Berkeley sickle cell mice are used as an animal model for human sickle cell disease, we investigated the progression of the histopathology in these animals over 6 months and compared these findings to those published in humans with sickle cell disease. The murine study groups were composed of wild-type mixed C57Bl/6-SV129 (control) mice and sickle cell (SS) mice (alpha-/-, beta-/-, transgene +) of both sexes and between 1 and 6 months of age. SS mice were similar to humans with sickle cell disease in having erythrocytic sickling, vascular ectasia, intravascular hemolysis, exuberant hematopoiesis, cardiomegaly, glomerulosclerosis, visceral congestion, hemorrhages, multiorgan infarcts, pyknotic neurons, and progressive siderosis. Cerebral perfusion studies demonstrated increased blood-brain barrier permeability in SS mice. SS mice differed from humans with sickle cell disease in having splenomegaly, splenic hematopoiesis, more severe hepatic infarcts, less severe pulmonary manifestations, no significant vascular intimal hyperplasia, and only a trend toward vascular medial hypertrophy. Early retinal degeneration caused by a homozygous mutation (rd1) independent from that causing sickle hemoglobin was an incidental finding in some Berkeley mice. While our study reinforces the fundamental strength of this model, the notable differences warrant careful consideration when drawing parallels to human sickle cell disease.
Figures




Comment in
-
Pathology of "Berkeley" sickle-cell mice includes gallstones and priapism.Blood. 2006 Apr 15;107(8):3414-5. doi: 10.1182/blood-2005-11-4500. Blood. 2006. PMID: 16597602 No abstract available.
Similar articles
-
Morphological and functional platelet abnormalities in Berkeley sickle cell mice.Blood Cells Mol Dis. 2008 Jul-Aug;41(1):109-18. doi: 10.1016/j.bcmd.2008.01.008. Epub 2008 Apr 18. Blood Cells Mol Dis. 2008. PMID: 18374611 Free PMC article.
-
Metabolic and Proteomic Divergence is Present in Spleens and Livers from Berkeley Sickle Cell Anemia and β-Thalassemia Mice.J Proteome Res. 2025 Mar 7;24(3):1306-1316. doi: 10.1021/acs.jproteome.4c00814. Epub 2025 Feb 13. J Proteome Res. 2025. PMID: 39947632
-
Knockout-transgenic mouse model of sickle cell disease.Science. 1997 Oct 31;278(5339):873-6. doi: 10.1126/science.278.5339.873. Science. 1997. PMID: 9346487
-
Transgenic mouse models of sickle cell disease.Curr Opin Hematol. 1996 Mar;3(2):150-5. doi: 10.1097/00062752-199603020-00008. Curr Opin Hematol. 1996. PMID: 9372066 Review.
-
Sickle cell disease, vasculopathy, and therapeutics.Annu Rev Med. 2013;64:451-66. doi: 10.1146/annurev-med-120611-143127. Epub 2012 Nov 26. Annu Rev Med. 2013. PMID: 23190149 Review.
Cited by
-
Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery.J Control Release. 2013 Oct 28;171(2):184-92. doi: 10.1016/j.jconrel.2013.07.008. Epub 2013 Jul 18. J Control Release. 2013. PMID: 23871960 Free PMC article.
-
A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H328-36. doi: 10.1152/ajpheart.00500.2012. Epub 2012 Nov 2. Am J Physiol Heart Circ Physiol. 2013. PMID: 23125208 Free PMC article.
-
Sensitization of nociceptors and dorsal horn neurons contributes to pain in sickle cell disease.Neurosci Lett. 2019 Jul 13;705:20-26. doi: 10.1016/j.neulet.2019.04.013. Epub 2019 Apr 14. Neurosci Lett. 2019. PMID: 30995520 Free PMC article. Review.
-
Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation.J Sex Med. 2015 Sep;12(9):1878-85. doi: 10.1111/jsm.12976. Epub 2015 Sep 7. J Sex Med. 2015. PMID: 26346631 Free PMC article.
-
Cognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum.Neurobiol Dis. 2016 Jan;85:60-72. doi: 10.1016/j.nbd.2015.10.004. Epub 2015 Oct 14. Neurobiol Dis. 2016. PMID: 26462816 Free PMC article.
References
-
- Paszty C. Transgenic and gene knock-out mouse models of sickle cell anemia and the thalassemias. Curr Opin Hematol. 1997;4: 88-93. - PubMed
-
- Paszty C, Brion CM, Manci E, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997; 278: 876-878. - PubMed
-
- de Jong K, Emerson RK, Butler J, Bastacky J, Mohandas N, Kuypers FA. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. Blood. 2001;98: 1577-1584. - PubMed
-
- Fabry ME, Suzuka SM, Weinberg RS, et al. Second generation knockout sickle mice: the effect of HbF. Blood. 2001;97: 410-418. - PubMed
-
- Kean LS, Manci EA, Perry J, et al. Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease. Blood. 2003;102: 4582-4593. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases